证券日报网讯新和成11月24日发布公告，在公司回答调研者提问时表示，目前公司香精香料板块主要生 产芳樟醇系列、柠檬醛系列、叶醇系列、二氢茉莉酮酸甲酯、薄荷醇等多种香料，被广泛应用于个人护 理、家庭护理、化妆品和食品领域。公司以客户为中心，产品品类丰富能满足客户不同需求，后续公司 会通过持续优化产品结构、丰富香料产品品类，不断推出一体化、系列化、协同化的香料新品种，持续 提升产品核心竞争力，公司已在山东启动占地约千亩用于布局新产品，相关项目正处于前期筹备和分阶 段审批流程中。 （文章来源：证券日报） ...

证券代码：002001 证券简称：新和成 6、公司全氟己基辛烷项目进展情况？ 答：公司年产 45 吨全氟己基辛烷、15 吨全氟丁基戊烷项 目已具备生产能力，两款产品是治疗干眼症药物的重要原料药， 已取得药品注册。 7、公司草铵膦和精草铵膦的进展情况如何？ 4、公司在新材料板块的布局？公司对 PPS 业务有哪些发展 规划？ 答：公司致力于成为新材料行业的生力军，重点发展高性能 聚合物及关键中间体，适度发展材料下游应用，目前主要产品包 括聚苯硫醚（PPS）、高温尼龙（PPA）、IPDA、HDI、IPDI 等， 产品性能和品质可以达到国际先进水平。PPS 具有机械强度高、 耐高温、耐化学药品性、热稳定性好、电性能优良、耐辐射和阻 燃等优点，在新能源、半导体、高端制造等领域的需求增长显著， 公司 PPS 报批 3 万吨，公司 PPS 现有产能 2.2 万吨，后续公司将 结合公司战略规划和市场发展态势，稳步有序推进扩建产能项目 建设。 5、公司香料板块主要有哪些产品，增长动力在哪里？ 答：目前公司香精香料板块主要生产芳樟醇系列、柠檬醛系 列、叶醇系列、二氢茉莉酮酸甲酯、薄荷醇等多种香料，被广泛 应用于个人护理、家庭护理 ...

Core Viewpoint - The company Xinhecheng (002001) is focusing on expanding its fragrance and flavor segment, which includes a variety of products widely used in personal care, household care, cosmetics, and food industries [1] Summary by Relevant Categories Business Operations - The fragrance and flavor segment primarily produces a range of products including linalool, citral, leaf alcohol, dihydro jasmine ketone methyl ester, raspberry ketone, ligustral, and menthol [1] - The company is currently maintaining a good profitability level in its fragrance and flavor business [1] Strategic Development - Xinhecheng is planning to develop a new fragrance industrial park in Shandong, covering approximately 1,000 acres, with projects currently in the early preparation and phased approval process [1] - The company aims to continuously optimize its product structure and enrich its fragrance product categories to enhance overall competitiveness [1]

Financial Performance - In Q3 2025, the company achieved a revenue of 166.42 billion CNY, with a net profit attributable to shareholders of 55.41 billion CNY, reflecting a year-on-year revenue growth of 5.45% and a net profit increase of 33.37% [3] - The company has maintained steady growth through production and sales linkage, market expansion, and cost control measures [3] Product Development and Market Strategy - The company focuses on the "Chemical+" and "Biological+" strategies, targeting opportunities in nutrition products, new materials, flavoring agents, and active pharmaceutical ingredients [3] - In the human nutrition sector, the company offers a range of products including vitamins A, D3, E, C, coenzyme Q10, taurine, β-carotene, and lycopene, with a commitment to customized formulations for various applications [3] - The solid methionine production capacity is currently at 30,000 tons, with an expansion project underway [3] Strategic Partnerships and Projects - The company has partnered with Sinopec to establish a joint venture for a liquid methionine project, with a production capacity of 18,000 tons/year [3] - The nylon new materials project in Tianjin has commenced construction, focusing on an integrated production chain from adiponitrile to nylon 66 [4] Future Plans and Innovations - The company aims to enhance its core competitiveness in the new materials sector by developing high-performance polymers and key intermediates [4] - The company is expanding its flavor and fragrance segment, with plans for a new fragrance industrial park in Shandong [4] - The Heilongjiang base is focused on bio-fermentation products, with ongoing improvements in product lines and operational efficiency [4] International Expansion - Over 50% of the company's sales are from international markets, with established subsidiaries in regions including Hong Kong, Singapore, Germany, Mexico, Brazil, Japan, and Vietnam [6] - The company emphasizes overseas market expansion as part of its 2025 operational strategy [6] Employee Engagement and Incentives - The company is implementing a share buyback program with a total amount between 30 million to 360 million CNY, aimed at employee stock ownership plans to enhance motivation and align interests [6]

Financial Performance - The company achieved a revenue of 11.1 billion CNY, representing a year-on-year growth of 12.76% [3] - The total profit reached 4.2 billion CNY, marking a significant increase of 56.68% compared to the previous year [3] - Net profit attributable to shareholders was 3.6 billion CNY, reflecting a growth of 36.03% [3] Business Segments - The liquid methionine project is in trial production, with a capacity of 180,000 tons/year, and is expected to undergo maintenance for 3-4 weeks [3] - The new materials segment generated a revenue of 1.038 billion CNY, up 43.75% year-on-year, driven by demand in new energy and high-end manufacturing [4] - The fragrance and flavor segment reported a revenue of 2.105 billion CNY, with plans for product optimization and expansion [4] Strategic Initiatives - The company is focusing on international expansion, with exports accounting for 58.04% of total sales, reaching over 100 countries [6] - Future investments will prioritize new materials, including the nylon project in Tianjin, expected to commence production in 2027 [6] - The company plans to distribute cash dividends of 6.12 CNY per share, totaling 1.5 billion CNY, subject to shareholder approval [8] Market Outlook - The company aims to enhance its competitive edge through innovation and a focus on sustainable development, aligning with the "anti-involution" policy to foster a healthy market environment [8] - The strategic focus will remain on fine chemicals, health nutrition, new materials, and raw pharmaceutical ingredients [6]

Group 1: Production and Sales - The company has an annual production capacity of 300,000 tons for solid methionine, with a high utilization rate and strong sales performance [2][3] - The liquid methionine project in cooperation with Sinopec, with a capacity of 180,000 tons, has entered the trial production phase and has successfully produced qualified products [3] Group 2: Fragrance and Flavor Products - The fragrance segment includes products such as linalool, citral, and menthol, widely used in personal care, household care, cosmetics, and food [3] - The company is focusing on optimizing product structure and expanding its fragrance product range to enhance core competitiveness [3][4] Group 3: New Materials Sector - The new materials sector is seen as having significant market potential, with a focus on high-performance polymers and key intermediates [3][4] - The Tianjin nylon new materials project is currently in the approval stage, with environmental assessments completed [4] Group 4: Biological Fermentation Products - The Heilongjiang base is focused on biological fermentation products, including Vitamin C and various amino acids, with efforts to improve efficiency and expand the product line [4] - The base aims to develop new products through a technology-first approach, enhancing synergy with existing business segments [4] Group 5: Employee Incentives and Shareholder Returns - The company has completed its employee stock ownership plan and is considering future equity incentive methods to attract talent [4][5] - Since its listing, the company has distributed a total of 15.5 billion yuan in dividends, representing 30%-50% of annual net profits, and is actively repurchasing shares within a range of 300 million to 600 million yuan [5]

Group 1: Company Overview and Strategy - The company operates under two main technology platforms: "Chemical+" and "Biological+" [3] - The focus is on expanding the biological fermentation product line, including vitamins and amino acids [3][4] - The company aims to develop new products in the fields of nutrition, new materials, and flavoring agents [6] Group 2: Financial Performance - The flavor and fragrance segment achieved a revenue of 3.916 billion RMB in 2024, representing a year-on-year growth of 19.62% [4] - Cumulative dividend payments have reached 15.5 billion RMB, with a payout ratio of 30%-50% of annual net profit [8] - The company has implemented two cash dividends in 2025, totaling 2 RMB and 5 RMB per share [8] Group 3: Investment and Development - The company is investing in high-performance polymers and key intermediates, with applications in automotive and electronics [4] - A new liquid methionine project is in the trial production preparation stage [5] - The Tianjin nylon new materials project is awaiting approval for construction [5] Group 4: Market Expansion and Global Strategy - The company exports to over 100 countries, with more than 50% of sales coming from international markets [6] - Plans for overseas factories are being considered, with existing subsidiaries in regions like Hong Kong, Singapore, and Germany [6] Group 5: Innovation and Competitive Position - The company emphasizes innovation and collaboration to enhance product competitiveness [6] - It aims to achieve domestic production of key products like vitamins E and A, contributing to industry transformation [6] - The company is focused on deepening its product matrix and expanding its market presence [6]